UTI Group: Revenue Up 21.1%, but Still in Loss

Revenue of 12.78 M€, Up 21.1%

As of June 30, 2026, UTI Group achieved revenue of 12.78 M€, compared to 10.55 M€ a year earlier, representing growth of 21.1%. According to the company, this change is mainly driven by the momentum of subsidiaries established in the regions, whose revenue increased by 77% over the period.

This growth notably benefits from the development of a significant customer contract, although the margin level remains limited, according to the group.

Operating and Net Loss Reduced Year-on-Year

Operating profit stands at -332 K€ as of June 30, 2026, compared to -459 K€ as of June 30, 2025. The operating margin rate came in at -2.6%, compared to -4.3% a year earlier. Net profit (group share) reached -339 K€, compared to -411 K€ in the first half of 2025.

The cost of financial debt increased from -78 K€ to -107 K€, and the profit before tax from ordinary activities stands at -436 K€, compared to -534 K€. The group is operating in a sluggish market environment marked by strong competitive pressure, which continues to weigh on its margin levels and profitability.

Equity at 162 K€ and Break-Even Target in 2027

As of June 30, 2026, the group's equity stands at 162 K€, compared to 518 K€ at December 31, 2025. This change is mainly explained by the loss recorded during the first half of 2026, in the absence of any new capital transactions during the period.

For the second half of 2026, UTI Group indicates that it is continuing its profitability improvement and cost optimization initiatives, with the objective of progressively strengthening its financial structure and returning to break-even in 2027.